| UniProt ID | H2B3B_HUMAN | |
|---|---|---|
| UniProt AC | Q8N257 | |
| Protein Name | Histone H2B type 3-B | |
| Gene Name | HIST3H2BB | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 126 | |
| Subcellular Localization | Nucleus. Chromosome. | |
| Protein Description | Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.. | |
| Protein Sequence | MPDPSKSAPAPKKGSKKAVTKAQKKDGKKRKRGRKESYSIYVYKVLKQVHPDTGISSKAMGIMNSFVNDIFERIASEASRLAHYNKRSTITSREVQTAVRLLLPGELAKHAVSEGTKAVTKYTSSK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MPDPSKSAP ------CCCCCCCCC | 63.32 | - | |
| 5 | Phosphorylation | ---MPDPSKSAPAPK ---CCCCCCCCCCCC | 46.77 | 20873877 | |
| 6 | N6-crotonyl-L-lysine | --MPDPSKSAPAPKK --CCCCCCCCCCCCC | 56.90 | - | |
| 6 | Acetylation | --MPDPSKSAPAPKK --CCCCCCCCCCCCC | 56.90 | 16283522 | |
| 6 | Butyrylation | --MPDPSKSAPAPKK --CCCCCCCCCCCCC | 56.90 | 27105113 | |
| 6 | Crotonylation | --MPDPSKSAPAPKK --CCCCCCCCCCCCC | 56.90 | 21925322 | |
| 6 | Lactoylation | --MPDPSKSAPAPKK --CCCCCCCCCCCCC | 56.90 | 31645732 | |
| 6 | Lactylation | --MPDPSKSAPAPKK --CCCCCCCCCCCCC | 56.90 | 31645732 | |
| 6 | Other | --MPDPSKSAPAPKK --CCCCCCCCCCCCC | 56.90 | 27105115 | |
| 6 | Sumoylation | --MPDPSKSAPAPKK --CCCCCCCCCCCCC | 56.90 | 16283522 | |
| 6 | Ubiquitination | --MPDPSKSAPAPKK --CCCCCCCCCCCCC | 56.90 | 33845483 | |
| 7 | Phosphorylation | -MPDPSKSAPAPKKG -CCCCCCCCCCCCCC | 43.77 | 20873877 | |
| 12 | N6-crotonyl-L-lysine | SKSAPAPKKGSKKAV CCCCCCCCCCCHHHH | 72.39 | - | |
| 12 | Acetylation | SKSAPAPKKGSKKAV CCCCCCCCCCCHHHH | 72.39 | 32155916 | |
| 12 | Crotonylation | SKSAPAPKKGSKKAV CCCCCCCCCCCHHHH | 72.39 | 21925322 | |
| 12 | Lactoylation | SKSAPAPKKGSKKAV CCCCCCCCCCCHHHH | 72.39 | 31645732 | |
| 12 | Lactylation | SKSAPAPKKGSKKAV CCCCCCCCCCCHHHH | 72.39 | 31645732 | |
| 12 | Other | SKSAPAPKKGSKKAV CCCCCCCCCCCHHHH | 72.39 | 27105115 | |
| 13 | N6-crotonyl-L-lysine | KSAPAPKKGSKKAVT CCCCCCCCCCHHHHH | 68.32 | - | |
| 13 | Acetylation | KSAPAPKKGSKKAVT CCCCCCCCCCHHHHH | 68.32 | 16283522 | |
| 13 | Crotonylation | KSAPAPKKGSKKAVT CCCCCCCCCCHHHHH | 68.32 | 21925322 | |
| 13 | Other | KSAPAPKKGSKKAVT CCCCCCCCCCHHHHH | 68.32 | 24681537 | |
| 15 | Phosphorylation | APAPKKGSKKAVTKA CCCCCCCCHHHHHHH | 39.60 | 1137958 | |
| 16 | N6-crotonyl-L-lysine | PAPKKGSKKAVTKAQ CCCCCCCHHHHHHHH | 54.11 | - | |
| 16 | Acetylation | PAPKKGSKKAVTKAQ CCCCCCCHHHHHHHH | 54.11 | 16283522 | |
| 16 | Crotonylation | PAPKKGSKKAVTKAQ CCCCCCCHHHHHHHH | 54.11 | 21925322 | |
| 16 | Lactoylation | PAPKKGSKKAVTKAQ CCCCCCCHHHHHHHH | 54.11 | 31645732 | |
| 17 | N6-crotonyl-L-lysine | APKKGSKKAVTKAQK CCCCCCHHHHHHHHH | 50.19 | - | |
| 17 | Acetylation | APKKGSKKAVTKAQK CCCCCCHHHHHHHHH | 50.19 | 16627869 | |
| 17 | Crotonylation | APKKGSKKAVTKAQK CCCCCCHHHHHHHHH | 50.19 | 21925322 | |
| 17 | Glutarylation | APKKGSKKAVTKAQK CCCCCCHHHHHHHHH | 50.19 | 31542297 | |
| 17 | Lactoylation | APKKGSKKAVTKAQK CCCCCCHHHHHHHHH | 50.19 | 31645732 | |
| 17 | Other | APKKGSKKAVTKAQK CCCCCCHHHHHHHHH | 50.19 | 27105115 | |
| 17 | Ubiquitination | APKKGSKKAVTKAQK CCCCCCHHHHHHHHH | 50.19 | 25015289 | |
| 21 | N6-crotonyl-L-lysine | GSKKAVTKAQKKDGK CCHHHHHHHHHHCCC | 42.07 | - | |
| 21 | Acetylation | GSKKAVTKAQKKDGK CCHHHHHHHHHHCCC | 42.07 | 16283522 | |
| 21 | Butyrylation | GSKKAVTKAQKKDGK CCHHHHHHHHHHCCC | 42.07 | 27105113 | |
| 21 | Crotonylation | GSKKAVTKAQKKDGK CCHHHHHHHHHHCCC | 42.07 | 21925322 | |
| 21 | Lactoylation | GSKKAVTKAQKKDGK CCHHHHHHHHHHCCC | 42.07 | 31645732 | |
| 21 | Other | GSKKAVTKAQKKDGK CCHHHHHHHHHHCCC | 42.07 | 27105115 | |
| 21 | Sumoylation | GSKKAVTKAQKKDGK CCHHHHHHHHHHCCC | 42.07 | 16283522 | |
| 21 | Ubiquitination | GSKKAVTKAQKKDGK CCHHHHHHHHHHCCC | 42.07 | 25015289 | |
| 24 | N6-crotonyl-L-lysine | KAVTKAQKKDGKKRK HHHHHHHHHCCCCCC | 58.66 | - | |
| 24 | Acetylation | KAVTKAQKKDGKKRK HHHHHHHHHCCCCCC | 58.66 | 24431477 | |
| 24 | Crotonylation | KAVTKAQKKDGKKRK HHHHHHHHHCCCCCC | 58.66 | 21925322 | |
| 24 | Lactoylation | KAVTKAQKKDGKKRK HHHHHHHHHCCCCCC | 58.66 | 31645732 | |
| 24 | Other | KAVTKAQKKDGKKRK HHHHHHHHHCCCCCC | 58.66 | 24681537 | |
| 24 | Ubiquitination | KAVTKAQKKDGKKRK HHHHHHHHHCCCCCC | 58.66 | 25015289 | |
| 25 | Acetylation | AVTKAQKKDGKKRKR HHHHHHHHCCCCCCC | 60.68 | 24848081 | |
| 25 | Other | AVTKAQKKDGKKRKR HHHHHHHHCCCCCCC | 60.68 | 24681537 | |
| 35 | N6-crotonyl-L-lysine | KKRKRGRKESYSIYV CCCCCCCCHHHHHHH | 54.56 | - | |
| 35 | Crotonylation | KKRKRGRKESYSIYV CCCCCCCCHHHHHHH | 54.56 | 21925322 | |
| 35 | Glutarylation | KKRKRGRKESYSIYV CCCCCCCCHHHHHHH | 54.56 | 31542297 | |
| 35 | Other | KKRKRGRKESYSIYV CCCCCCCCHHHHHHH | 54.56 | 27105115 | |
| 35 | Succinylation | KKRKRGRKESYSIYV CCCCCCCCHHHHHHH | 54.56 | 22389435 | |
| 35 | Ubiquitination | KKRKRGRKESYSIYV CCCCCCCCHHHHHHH | 54.56 | 21890473 | |
| 37 | Phosphorylation | RKRGRKESYSIYVYK CCCCCCHHHHHHHHH | 27.50 | 21712546 | |
| 38 | Phosphorylation | KRGRKESYSIYVYKV CCCCCHHHHHHHHHH | 10.52 | 28152594 | |
| 39 | Phosphorylation | RGRKESYSIYVYKVL CCCCHHHHHHHHHHH | 19.40 | 21712546 | |
| 41 | Phosphorylation | RKESYSIYVYKVLKQ CCHHHHHHHHHHHHH | 7.56 | 28152594 | |
| 43 | Phosphorylation | ESYSIYVYKVLKQVH HHHHHHHHHHHHHHC | 4.38 | 28152594 | |
| 44 | Acetylation | SYSIYVYKVLKQVHP HHHHHHHHHHHHHCC | 30.92 | - | |
| 44 | Glutarylation | SYSIYVYKVLKQVHP HHHHHHHHHHHHHCC | 30.92 | 31542297 | |
| 44 | Lactoylation | SYSIYVYKVLKQVHP HHHHHHHHHHHHHCC | 30.92 | 31645732 | |
| 44 | Other | SYSIYVYKVLKQVHP HHHHHHHHHHHHHCC | 30.92 | 24681537 | |
| 44 | Ubiquitination | SYSIYVYKVLKQVHP HHHHHHHHHHHHHCC | 30.92 | 23000965 | |
| 47 | Acetylation | IYVYKVLKQVHPDTG HHHHHHHHHHCCCCC | 53.94 | 37092721 | |
| 47 | Glutarylation | IYVYKVLKQVHPDTG HHHHHHHHHHCCCCC | 53.94 | 31542297 | |
| 47 | Methylation | IYVYKVLKQVHPDTG HHHHHHHHHHCCCCC | 53.94 | 16627869 | |
| 47 | Other | IYVYKVLKQVHPDTG HHHHHHHHHHCCCCC | 53.94 | 24681537 | |
| 47 | Sumoylation | IYVYKVLKQVHPDTG HHHHHHHHHHCCCCC | 53.94 | 16627869 | |
| 47 | Ubiquitination | IYVYKVLKQVHPDTG HHHHHHHHHHCCCCC | 53.94 | 21906983 | |
| 53 | Phosphorylation | LKQVHPDTGISSKAM HHHHCCCCCCCHHHH | 40.65 | 30266825 | |
| 56 | Phosphorylation | VHPDTGISSKAMGIM HCCCCCCCHHHHHHH | 27.42 | 23401153 | |
| 57 | Phosphorylation | HPDTGISSKAMGIMN CCCCCCCHHHHHHHH | 23.63 | 30266825 | |
| 58 | "N6,N6-dimethyllysine" | PDTGISSKAMGIMNS CCCCCCHHHHHHHHH | 35.29 | - | |
| 58 | Acetylation | PDTGISSKAMGIMNS CCCCCCHHHHHHHHH | 35.29 | 24431487 | |
| 58 | Methylation | PDTGISSKAMGIMNS CCCCCCHHHHHHHHH | 35.29 | 16627869 | |
| 58 | Other | PDTGISSKAMGIMNS CCCCCCHHHHHHHHH | 35.29 | 24681537 | |
| 58 | Ubiquitination | PDTGISSKAMGIMNS CCCCCCHHHHHHHHH | 35.29 | 21906983 | |
| 60 | Sulfoxidation | TGISSKAMGIMNSFV CCCCHHHHHHHHHHH | 4.26 | 28183972 | |
| 63 | Sulfoxidation | SSKAMGIMNSFVNDI CHHHHHHHHHHHHHH | 2.59 | 28183972 | |
| 65 | Phosphorylation | KAMGIMNSFVNDIFE HHHHHHHHHHHHHHH | 17.12 | 22617229 | |
| 73 | Methylation | FVNDIFERIASEASR HHHHHHHHHHHHHHH | 21.01 | - | |
| 76 | Phosphorylation | DIFERIASEASRLAH HHHHHHHHHHHHHHH | 31.18 | 22817900 | |
| 79 | Phosphorylation | ERIASEASRLAHYNK HHHHHHHHHHHHHCC | 24.63 | 22817900 | |
| 80 | Methylation | RIASEASRLAHYNKR HHHHHHHHHHHHCCC | 42.83 | - | |
| 84 | Phosphorylation | EASRLAHYNKRSTIT HHHHHHHHCCCCCCC | 19.44 | 25884760 | |
| 86 | "N6,N6,N6-trimethyllysine" | SRLAHYNKRSTITSR HHHHHHCCCCCCCHH | 40.33 | - | |
| 86 | Acetylation | SRLAHYNKRSTITSR HHHHHHCCCCCCCHH | 40.33 | 30589229 | |
| 86 | Lactoylation | SRLAHYNKRSTITSR HHHHHHCCCCCCCHH | 40.33 | 31645732 | |
| 86 | Methylation | SRLAHYNKRSTITSR HHHHHHCCCCCCCHH | 40.33 | - | |
| 86 | Other | SRLAHYNKRSTITSR HHHHHHCCCCCCCHH | 40.33 | 27105115 | |
| 86 | Ubiquitination | SRLAHYNKRSTITSR HHHHHHCCCCCCCHH | 40.33 | 27667366 | |
| 87 | Methylation | RLAHYNKRSTITSRE HHHHHCCCCCCCHHH | 35.08 | - | |
| 88 | Phosphorylation | LAHYNKRSTITSREV HHHHCCCCCCCHHHH | 26.27 | 30266825 | |
| 89 | Phosphorylation | AHYNKRSTITSREVQ HHHCCCCCCCHHHHH | 32.10 | 30266825 | |
| 91 | Phosphorylation | YNKRSTITSREVQTA HCCCCCCCHHHHHHH | 23.09 | 30266825 | |
| 92 | Phosphorylation | NKRSTITSREVQTAV CCCCCCCHHHHHHHH | 23.69 | 20860994 | |
| 93 | Methylation | KRSTITSREVQTAVR CCCCCCHHHHHHHHH | 39.18 | - | |
| 100 | Methylation | REVQTAVRLLLPGEL HHHHHHHHHHCCHHH | 19.70 | 115387663 | |
| 109 | Ubiquitination | LLPGELAKHAVSEGT HCCHHHHHHHHHHHH | 44.73 | 21890473 | |
| 109 | Sumoylation | LLPGELAKHAVSEGT HCCHHHHHHHHHHHH | 44.73 | - | |
| 109 | Acetylation | LLPGELAKHAVSEGT HCCHHHHHHHHHHHH | 44.73 | 30589247 | |
| 109 | Glutarylation | LLPGELAKHAVSEGT HCCHHHHHHHHHHHH | 44.73 | 31542297 | |
| 109 | Lactoylation | LLPGELAKHAVSEGT HCCHHHHHHHHHHHH | 44.73 | 31645732 | |
| 109 | Methylation | LLPGELAKHAVSEGT HCCHHHHHHHHHHHH | 44.73 | 16627869 | |
| 109 | Neddylation | LLPGELAKHAVSEGT HCCHHHHHHHHHHHH | 44.73 | 32015554 | |
| 109 | Other | LLPGELAKHAVSEGT HCCHHHHHHHHHHHH | 44.73 | 24681537 | |
| 109 | Sumoylation | LLPGELAKHAVSEGT HCCHHHHHHHHHHHH | 44.73 | 16627869 | |
| 109 | Ubiquitination | LLPGELAKHAVSEGT HCCHHHHHHHHHHHH | 44.73 | 23000965 | |
| 113 | O-linked_Glycosylation | ELAKHAVSEGTKAVT HHHHHHHHHHHHHHH | 30.96 | UniProtKB CARBOHYD | |
| 113 | Phosphorylation | ELAKHAVSEGTKAVT HHHHHHHHHHHHHHH | 30.96 | 28176443 | |
| 116 | Phosphorylation | KHAVSEGTKAVTKYT HHHHHHHHHHHHHHC | 16.27 | 20068231 | |
| 117 | Sumoylation | HAVSEGTKAVTKYTS HHHHHHHHHHHHHCC | 52.28 | - | |
| 117 | Acetylation | HAVSEGTKAVTKYTS HHHHHHHHHHHHHCC | 52.28 | 22389435 | |
| 117 | Glutarylation | HAVSEGTKAVTKYTS HHHHHHHHHHHHHCC | 52.28 | 31542297 | |
| 117 | Lactoylation | HAVSEGTKAVTKYTS HHHHHHHHHHHHHCC | 52.28 | 31645732 | |
| 117 | Malonylation | HAVSEGTKAVTKYTS HHHHHHHHHHHHHCC | 52.28 | 22389435 | |
| 117 | Methylation | HAVSEGTKAVTKYTS HHHHHHHHHHHHHCC | 52.28 | - | |
| 117 | Neddylation | HAVSEGTKAVTKYTS HHHHHHHHHHHHHCC | 52.28 | 32015554 | |
| 117 | Other | HAVSEGTKAVTKYTS HHHHHHHHHHHHHCC | 52.28 | 27105115 | |
| 117 | Succinylation | HAVSEGTKAVTKYTS HHHHHHHHHHHHHCC | 52.28 | 22389435 | |
| 117 | Sumoylation | HAVSEGTKAVTKYTS HHHHHHHHHHHHHCC | 52.28 | 22389435 | |
| 117 | Ubiquitination | HAVSEGTKAVTKYTS HHHHHHHHHHHHHCC | 52.28 | 23000965 | |
| 120 | Phosphorylation | SEGTKAVTKYTSSK- HHHHHHHHHHCCCC- | 24.16 | 20068231 | |
| 121 | Ubiquitination | EGTKAVTKYTSSK-- HHHHHHHHHCCCC-- | 39.67 | 21890473 | |
| 121 | Sumoylation | EGTKAVTKYTSSK-- HHHHHHHHHCCCC-- | 39.67 | - | |
| 121 | Acetylation | EGTKAVTKYTSSK-- HHHHHHHHHCCCC-- | 39.67 | 30589235 | |
| 121 | Glutarylation | EGTKAVTKYTSSK-- HHHHHHHHHCCCC-- | 39.67 | 31542297 | |
| 121 | Lactoylation | EGTKAVTKYTSSK-- HHHHHHHHHCCCC-- | 39.67 | 31645732 | |
| 121 | Neddylation | EGTKAVTKYTSSK-- HHHHHHHHHCCCC-- | 39.67 | 32015554 | |
| 121 | Other | EGTKAVTKYTSSK-- HHHHHHHHHCCCC-- | 39.67 | 27105115 | |
| 121 | Succinylation | EGTKAVTKYTSSK-- HHHHHHHHHCCCC-- | 39.67 | 22389435 | |
| 121 | Sumoylation | EGTKAVTKYTSSK-- HHHHHHHHHCCCC-- | 39.67 | 22389435 | |
| 121 | Ubiquitination | EGTKAVTKYTSSK-- HHHHHHHHHCCCC-- | 39.67 | 22389435 | |
| 122 | Phosphorylation | GTKAVTKYTSSK--- HHHHHHHHCCCC--- | 11.50 | - | |
| 123 | Phosphorylation | TKAVTKYTSSK---- HHHHHHHCCCC---- | 28.25 | 24719451 | |
| 124 | Phosphorylation | KAVTKYTSSK----- HHHHHHCCCC----- | 32.80 | 27251275 | |
| 126 | Acetylation | VTKYTSSK------- HHHHCCCC------- | 65.21 | 30589253 | |
| 126 | Neddylation | VTKYTSSK------- HHHHCCCC------- | 65.21 | 32015554 | |
| 126 | Ubiquitination | VTKYTSSK------- HHHHCCCC------- | 65.21 | 23000965 |
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 4 | K | Methylation |
| 16627869 |
| 4 | K | Methylation |
| 16627869 |
| 4 | K | ubiquitylation |
| 16627869 |
| 4 | K | ubiquitylation |
| 16627869 |
| 15 | S | Phosphorylation |
| 12757711 |
| 15 | S | Phosphorylation |
| 12757711 |
| 35 | K | Methylation |
| 21925322 |
| 35 | K | ubiquitylation |
| 21925322 |
| 37 | S | Phosphorylation |
| 12757711 |
| 79 | K | Methylation |
| 16627869 |
| 79 | K | Methylation |
| 16627869 |
| 79 | K | ubiquitylation |
| 16627869 |
| 79 | K | ubiquitylation |
| 16627869 |
| 113 | S | ubiquitylation |
| - |
| 121 | K | ubiquitylation |
| 16627869 |
| 121 | K | ubiquitylation |
| 16627869 |
| 121 | K | Methylation |
| 16627869 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of H2B3B_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| HDAC1_HUMAN | HDAC1 | physical | 21846774 | |
| CDN2A_HUMAN | CDKN2A | physical | 21846774 | |
| ARF_HUMAN | CDKN2A | physical | 21846774 | |
| RL5_HUMAN | RPL5 | physical | 21846774 | |
| HUWE1_HUMAN | HUWE1 | physical | 21846774 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-86 AND LYS-121, AND MASSSPECTROMETRY. | |
| "Substrate and functional diversity of lysine acetylation revealed bya proteomics survey."; Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.; Mol. Cell 23:607-618(2006). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-12; LYS-13; LYS-16; LYS-17;LYS-21; LYS-24 AND LYS-109, AND MASS SPECTROMETRY. | |
| "Inhibition of core histones acetylation by carcinogenic nickel(II)."; Golebiowski F., Kasprzak K.S.; Mol. Cell. Biochem. 279:133-139(2005). Cited for: ACETYLATION AT LYS-6; LYS-13; LYS-16 AND LYS-21. | |
| "Quantitative proteomic analysis of post-translational modificationsof human histones."; Beck H.C., Nielsen E.C., Matthiesen R., Jensen L.H., Sehested M.,Finn P., Grauslund M., Hansen A.M., Jensen O.N.; Mol. Cell. Proteomics 5:1314-1325(2006). Cited for: PROTEIN SEQUENCE OF 7-24, ACETYLATION AT LYS-6; LYS-12; LYS-13;LYS-16; LYS-17 AND LYS-21, METHYLATION AT LYS-47; LYS-58 AND LYS-109,UBIQUITINATION AT LYS-121, AND MASS SPECTROMETRY. | |
| Methylation | |
| Reference | PubMed |
| "Quantitative proteomic analysis of post-translational modificationsof human histones."; Beck H.C., Nielsen E.C., Matthiesen R., Jensen L.H., Sehested M.,Finn P., Grauslund M., Hansen A.M., Jensen O.N.; Mol. Cell. Proteomics 5:1314-1325(2006). Cited for: PROTEIN SEQUENCE OF 7-24, ACETYLATION AT LYS-6; LYS-12; LYS-13;LYS-16; LYS-17 AND LYS-21, METHYLATION AT LYS-47; LYS-58 AND LYS-109,UBIQUITINATION AT LYS-121, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Apoptotic phosphorylation of histone H2B is mediated by mammaliansterile twenty kinase."; Cheung W.L., Ajiro K., Samejima K., Kloc M., Cheung P., Mizzen C.A.,Beeser A., Etkin L.D., Chernoff J., Earnshaw W.C., Allis C.D.; Cell 113:507-517(2003). Cited for: PHOSPHORYLATION AT SER-15. | |
| Ubiquitylation | |
| Reference | PubMed |
| "Histone H2B monoubiquitination functions cooperatively with FACT toregulate elongation by RNA polymerase II."; Pavri R., Zhu B., Li G., Trojer P., Mandal S., Shilatifard A.,Reinberg D.; Cell 125:703-717(2006). Cited for: UBIQUITINATION AT LYS-121. | |
| "Monoubiquitination of human histone H2B: the factors involved andtheir roles in HOX gene regulation."; Zhu B., Zheng Y., Pham A.-D., Mandal S.S., Erdjument-Bromage H.,Tempst P., Reinberg D.; Mol. Cell 20:601-611(2005). Cited for: UBIQUITINATION AT LYS-121. | |
| "Quantitative proteomic analysis of post-translational modificationsof human histones."; Beck H.C., Nielsen E.C., Matthiesen R., Jensen L.H., Sehested M.,Finn P., Grauslund M., Hansen A.M., Jensen O.N.; Mol. Cell. Proteomics 5:1314-1325(2006). Cited for: PROTEIN SEQUENCE OF 7-24, ACETYLATION AT LYS-6; LYS-12; LYS-13;LYS-16; LYS-17 AND LYS-21, METHYLATION AT LYS-47; LYS-58 AND LYS-109,UBIQUITINATION AT LYS-121, AND MASS SPECTROMETRY. | |